Spinocerebellar ataxia, type 3 (SCA3) is genetically identical to Machado-Joseph disease (MJD)
- PMID: 8523034
- DOI: 10.1016/0022-510x(95)90927-i
Spinocerebellar ataxia, type 3 (SCA3) is genetically identical to Machado-Joseph disease (MJD)
Abstract
Spinocerebellar ataxia, type 3 (SCA3) and Machado-Joseph disease (MJD) are two clinically distinct representatives of the heterogeneous group of autosomal dominant cerebellar ataxias. Assignment of the disease genes to the same region of the long arm of chromosome 14 in both SCA3 and MJD suggested that these two disorders are genetically identical. The recent identification of a trinucleotide (CAG) repeat expansion in a gene underlying MJD facilitates assessment of this hypothesis. We analysed the MJD gene in members of a family with characteristic features of SCA3 and no symptoms typical of MJD. We found the same trinucleotide repeat expansion within the gene that was previously described in patients with MJD. The findings demonstrate that SCA3 and MJD are genetically identical in spite of their pronounced clinical differences. Furthermore, we demonstrate a striking variation in the copy number of the CAG repeat among affected members of the same family.
Similar articles
-
Detection of the Machado-Joseph disease/spinocerebellar ataxia three trinucleotide repeat expansion in families with autosomal dominant motor disorders, including the Drew family of Walworth.Brain. 1995 Oct;118 ( Pt 5):1077-85. doi: 10.1093/brain/118.5.1077. Brain. 1995. PMID: 7496771
-
Spinocerebellar ataxia type 1 and Machado-Joseph disease: incidence of CAG expansions among adult-onset ataxia patients from 311 families with dominant, recessive, or sporadic ataxia.Am J Hum Genet. 1995 Sep;57(3):603-8. Am J Hum Genet. 1995. PMID: 7668288 Free PMC article.
-
Marked phenotypic heterogeneity associated with expansion of a CAG repeat sequence at the spinocerebellar ataxia 3/Machado-Joseph disease locus.Am J Hum Genet. 1995 Oct;57(4):809-16. Am J Hum Genet. 1995. PMID: 7573040 Free PMC article.
-
Dominantly inherited ataxias: lessons learned from Machado-Joseph disease/spinocerebellar ataxia type 3.Semin Neurol. 2007 Apr;27(2):133-42. doi: 10.1055/s-2007-971172. Semin Neurol. 2007. PMID: 17390258 Review.
-
Machado-Joseph disease/spinocerebellar ataxia type 3.Handb Clin Neurol. 2012;103:437-49. doi: 10.1016/B978-0-444-51892-7.00027-9. Handb Clin Neurol. 2012. PMID: 21827905 Free PMC article. Review.
Cited by
-
Slow saccades in cerebellar disease.Cerebellum Ataxias. 2019 Jan 17;6:1. doi: 10.1186/s40673-018-0095-9. eCollection 2019. Cerebellum Ataxias. 2019. PMID: 30680221 Free PMC article. Review.
-
Specific Biomarkers in Spinocerebellar Ataxia Type 3: A Systematic Review of Their Potential Uses in Disease Staging and Treatment Assessment.Int J Mol Sci. 2024 Jul 24;25(15):8074. doi: 10.3390/ijms25158074. Int J Mol Sci. 2024. PMID: 39125644 Free PMC article. Review.
-
Caloric restriction blocks neuropathology and motor deficits in Machado-Joseph disease mouse models through SIRT1 pathway.Nat Commun. 2016 May 11;7:11445. doi: 10.1038/ncomms11445. Nat Commun. 2016. PMID: 27165717 Free PMC article.
-
Pueraria lobata and Daidzein Reduce Cytotoxicity by Enhancing Ubiquitin-Proteasome System Function in SCA3-iPSC-Derived Neurons.Oxid Med Cell Longev. 2019 Oct 7;2019:8130481. doi: 10.1155/2019/8130481. eCollection 2019. Oxid Med Cell Longev. 2019. PMID: 31687087 Free PMC article.
-
Ataxin-3 protein and RNA toxicity in spinocerebellar ataxia type 3: current insights and emerging therapeutic strategies.Mol Neurobiol. 2014 Jun;49(3):1513-31. doi: 10.1007/s12035-013-8596-2. Epub 2013 Nov 29. Mol Neurobiol. 2014. PMID: 24293103 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources